A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a ...

A D-dimer test measures a protein fragment that remains in the blood after blood clots break down. It can help diagnose clotting conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), ...

Since its introduction to clinical use, the D-dimer test for deep venous thrombosis/pulmonary embolism has been a blessing and a curse. What is the current thinking regarding D-dimer use in clinical ...

DEAR DR. ROACH: What are D-dimers? Are they something I should be concerned about? I am an 83-year-old male with the usual problems that men my age have, such as an enlarged prostate, high blood ...

New research suggests that it may be possible to simplify the diagnosis of deep vein thrombosis (DVT) without compromising accuracy. Contrary to the standard practice of administering several tests to ...

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading across many parts of the world, and clinicians are working on recognizing biomarkers ...

Pulmonary embolism accounts for 10–15% of all paediatric venous thromboembolism (VTE) events, with an annual incidence of 0·14–0·9 per 100 000 children.1,2 Although rare, pulmonary embolism is a ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out ...

Feasibility of a prospective host cell reactivation assay (HCRA) in non-small cell lung cancer (NSCLC) patients. Background: Procoagulant changes in the haemostatic system and activation of ...

Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ADJUST-DVT trial. For patients ages 50 and older with a nonhigh or unlikely ...